CA
INSM icon

Continuum Advisory’s Insmed INSM Stock Holding History

Continuum Advisory’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-27
Closed -$2.06K – 980
2025
Q1 		$2.06K Hold
27
– – ﹤0.01% 1341
2024
Q4 		$1.86K Hold
27
– – ﹤0.01% 1439
2024
Q3 		$1.92K Buy
27
+13
+93% +$959 ﹤0.01% 1440
2024
Q2 		$938 Buy
+14
New +$543 ﹤0.01% 1486

Other funds holding INSM

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Continuum Advisory's INSM Position: Q2 2025 in Review

Continuum Advisory sold out of Insmed (INSM) in Q2 2025, closing a stake of 27 shares — an estimated $2.06K sold.

Continuum Advisory first reported a position in INSM in Q2 2024 and held it in 4 quarters. The position peaked at $2.06K in Q1 2025. 516 funds tracked by Wall St. Rank hold INSM as of Q2 2025.

  • Continuum Advisory reported no remaining Insmed position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 27 Insmed shares in Q2 2025, an estimated $2.06K.
  • Continuum Advisory first reported a position in Insmed in Q2 2024 and held it in 4 quarters.
  • Continuum Advisory's Insmed position peaked at $2.06K in Q1 2025.
  • 516 funds tracked by Wall St. Rank held Insmed as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.